Full Text
The Full Text of this article is available as a PDF (44.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bard F., Cannon C., Barbour R., Burke R. L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000 Aug;6(8):916–919. doi: 10.1038/78682. [DOI] [PubMed] [Google Scholar]
- Bleeker W. K., Teeling J. L., Verhoeven A. J., Rigter G. M., Agterberg J., Tool A. T., Koenderman A. H., Kuijpers T. W., Hack C. E. Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase. Blood. 2000 Mar 1;95(5):1856–1861. [PubMed] [Google Scholar]
- Chowdhury D., Wardlaw J. M., Dennis M. S. Are multiple acute small subcortical infarctions caused by embolic mechanisms? J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1416–1420. doi: 10.1136/jnnp.2004.038653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dalakas M. C. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med. 1997 May 1;126(9):721–730. doi: 10.7326/0003-4819-126-9-199705010-00008. [DOI] [PubMed] [Google Scholar]
- Dodel R. C., Du Y., Depboylu C., Hampel H., Frölich L., Haag A., Hemmeter U., Paulsen S., Teipel S. J., Brettschneider S. Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1472–1474. doi: 10.1136/jnnp.2003.033399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kang Dong-Wha, Chalela Julio A., Ezzeddine Mustapha A., Warach Steven. Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes. Arch Neurol. 2003 Dec;60(12):1730–1734. doi: 10.1001/archneur.60.12.1730. [DOI] [PubMed] [Google Scholar]
- Kang Dong-Wha, Latour Lawrence L., Chalela Julio A., Dambrosia James, Warach Steven. Early ischemic lesion recurrence within a week after acute ischemic stroke. Ann Neurol. 2003 Jul;54(1):66–74. doi: 10.1002/ana.10592. [DOI] [PubMed] [Google Scholar]
- Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M., Morgan T. E., Rozovsky I., Trommer B., Viola K. L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448–6453. doi: 10.1073/pnas.95.11.6448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leary Megan C., Saver Jeffrey L. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis. 2003;16(3):280–285. doi: 10.1159/000071128. [DOI] [PubMed] [Google Scholar]
- Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999 Jul 8;400(6740):173–177. doi: 10.1038/22124. [DOI] [PubMed] [Google Scholar]